Skip to main content

Change location

You are currently on the USA (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (Español)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • USA (English)
  • Careers
  • Media and News
  • Get in touch
  • Product Security
  • Sign up
    • USA (English)
    • We are Bracco
    • Bracco at a glance
    • Past, present, future
    • Our Foundation
    • Our business
    • Product overview
      • X-ray & CT
      • Medical devices

        • EmpowerCTA+
        • NEXO
        • PROTOCO2L TOUCH
      • Products

        • ISOVUE and Imaging Bulk Package
        • GASTROGRAFIN
        • READI-CAT 2 SMOOTHIE
        • READI-CAT 2
        • TAGITOL V
      • Fluoroscopy

        • VARIBAR
        • CYSTOGRAFIN
        • CYSTOGRAFIN-DILUTE
        • E-Z-DISK
        • E-Z-GAS II
        • E-Z-HD
        • E-Z-PAQUE
        • ENTERO VU
        • GASTROGRAFIN
        • Liquid E-Z-PAQUE
      • Myelography

        • ISOVUE-M 200/300
      • MRI
      • Contrast agents

        • VUEWAY
        • MultiHance
        • ProHance
      • Medical Devices

        • Max 3
        • EmpowerMR
      • AI

        • AiMIFY
      • Other

        • CitraClear™
      • CEUS
      • Contrast agents

        • LUMASON
      • Molecular imaging
      • Products

        • CardioGen-82
        • HeartSee
        • Kinevac
        • Choletec
      • Cardiology
      • Contrast agents

        • CardioGen-82
        • Lumason
        • ISOVUE
        • ACIST CVi
        • Heartsee
    • Digital health
    • Reimbursement
    • Oncology
    • Innovation
    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage
      • Cell Therapy
      • Research Products
        • BubbleGen CD3+ Cell Selection Kit
        • BubbleGen Cell Separators
      • Resources
    • Education
    • Partnerships and sponsorships
    • Events
  • Sustainability
  • Our Stories
152 results found
Article
Bracco Imaging earns its first EcoVadis Platinum Medal: in Global Top 1%
No image available
Article
Join us @ RSNA 2025 At RSNA 2025, Bracco Diagnostics Inc. is proud to spotlight its unwavering dedication to two distinct pillars shaping the future of radiology: education and sustainability. 
RSNA 2025
Article
RSNA 2025 - Cloned
No image available
Page
Scientific Information Inquiry Fill in this form to receive information about medical and clinical aspects of a product.
No image available
Article
Bracco Shapes the Future of Radiology at RSNA 2025 Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, will showcase a bold vision for radiology at the Radiological Society of North America (RSNA) 2025 Annual Meeting, to be held November 30 – December 4 in Chicago, Illinois.
Bracco Pillars
Article
Bracco Delivers 3 Million VUEWAY® Doses, Meeting Patient Demand for Lower-Dose MRI Contrast Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced today that more than three million doses1 of its magnetic resonance imaging (MRI) agent, VUEWAY® (gadopiclenol) solution for injection, intravenous use, have been administered across 902 customer sites.2
Vueway (gadopiclenol) injection 485.1 mg/ml
Article
FDA Approves Expanded Indication for Max 3™ Syringeless MR Injector from Bracco FDA Approval of VUEWAY® (gadopiclenol) injection Imaging Bulk Package (IBP) Enhances Options for Efficient, Sustainable MRI Contrast Delivery.
Vueway
Article
CMS Doubles Payment for Contrast-Enhanced Ultrasound Scans Provided by Business Wire - 25 November 2025
Bracco CEUS-Contrast Enhanced Ultrasound
Article
Innovation in Cell Therapy: Bracco Imaging Forms Strategic Partnership with CellBri We’re proud to announce a new partnership between Bracco Imaging Medical Technologies (Shanghai) and Shenzhen Cellbri Bio-Innovation Technology, aimed at transforming CAR-T cell therapy manufacturing — one of the most promising areas in personalized cancer treatment.
Bracco Imaging Forms Strategic Partnership with CellBri
Article
Bracco Enters Cell Therapy Manufacturing with Cell Selection and Activation Technologies Bracco Imaging today announced its first expansion into the cell therapy space, driven by its expertise and newly developed applications of its long-established microbubble technology.
Bracco Geneva Site
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • for Bracco VPN users

Bracco Copyright © 2026 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182